What is the Automated DNA/RNA Extraction market size in 2023?

The Automated DNA/RNA Extraction market size reached approximately USD 1.2 billion in 2023, driven by advancements in molecular diagnostics and genomic research.

What is the growth forecast for this market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, with increased adoption in clinical and research settings.

What are the key drivers of market growth?

Key drivers include rising demand for high-throughput testing, personalized medicine, and automation in labs to enhance efficiency and reduce errors.

What challenges does the market face?

Challenges include high equipment costs, technical complexity, and the need for skilled personnel to operate advanced systems.

Which regions lead the Automated DNA/RNA Extraction market?

North America dominates the market due to robust healthcare infrastructure, while Asia-Pacific shows rapid growth from expanding biotech sectors.

Who are the top companies in this market?

Leading players include Thermo Fisher Scientific, Qiagen, and PerkinElmer, offering innovative solutions for end-to-end nucleic acid extraction workflows.

What future opportunities exist in this market?

Opportunities lie in infectious disease diagnostics, cancer research, and decentralized testing, supported by AI-integrated automation technologies.

How is technology shaping the market?

Technological advancements like microfluidics, robotics, and cloud-based data analytics are enhancing precision, speed, and scalability in DNA/RNA extraction.

What is the regulatory landscape like?

Regulatory frameworks emphasize compliance with ISO standards and CLIA guidelines, ensuring accuracy and reproducibility in diagnostic and research applications.

Automated DNA/RNA Extraction Value Chain Analysis & Forecast Outlook 2033

Automated DNA/RNA Extraction by Application (Hospital, Laboratory, Clinic, Other), by Types (Human gDNA, Viral RNA/DNA, Bacteria DNA, Bacteria RNA, Cell-free DNA, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Automated DNA/RNA Extraction Market Overview

The Automated DNA/RNA Extraction market encompasses technologies and systems designed to streamline nucleic acid isolation processes in life sciences, diagnostics, and biopharmaceuticals. As precision medicine and genomic research advance, this market is pivotal in enabling high-throughput, scalable, and contamination-free sample processing. The Automated DNA/RNA Extraction market size is estimated at USD 1.2 billion in 2025, reflecting robust growth outlook and strategic significance in the biotech ecosystem. This industry expansion is driven by rising demand for rapid diagnostic tools, AI-integrated automation, and expanding applications in next-generation sequencing (NGS) and CRISPR-based therapies.

Loading chart…

The market is projected to grow at a CAGR of 8.5% from 2026 to 2033, fueled by macro drivers such as _AI-driven automation_, regulatory tailwinds for streamlined diagnostics, and surging R&D investments in oncology and infectious disease research. Key technological shifts include single-tube extraction systems and cloud-connected platforms enhancing data traceability. North America remains the largest region, while Asia-Pacific leads in growth potential due to expanding biobanking infrastructure and government-funded genomics initiatives. Strategic partnerships between automation providers and biopharma firms underscore competitive intensity, with supply-chain resilience emerging as a critical challenge amid global semiconductor shortages.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; General Biologicals Corporation (GBC); AutoGen; Biocompare; ELITechGroup; Analytik Jena AG; ADS Biotec; GeneReach; Biosan; Genolution; RBCBioscience; Biosynex; Qiagen; Promega Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for precision medicine is accelerating adoption of Automated DNA/RNA Extraction systems, as these platforms enable high-throughput processing critical for genomics-based diagnostics and drug development.

Advancements in next-generation sequencing (NGS) technologies are creating synergistic demand, with automated extraction systems required to prepare high-quality nucleic acids for complex sequencing workflows.

Restraints2 items

High capital expenditure for advanced automation systems remains a barrier, particularly for mid-sized labs and resource-constrained regions with limited access to financing.

Regulatory compliance complexities across regions, such as FDA 21 CFR Part 11 validation requirements, increase time-to-market and operational costs.

Opportunities2 items

Expansion into biobanking and agricultural genomics offers untapped potential, with automated systems supporting large-scale sample processing for genomic research and crop improvement initiatives.

Integration with AI-driven analytics platforms presents a strategic differentiator, enabling real-time data interpretation and predictive modeling to enhance diagnostic accuracy.

Challenges2 items

Technical limitations in handling complex samples (e.g., environmental or FFPE samples) persist, requiring R&D investments to improve extraction efficiency and reduce contamination risks.

Talent shortages in molecular biology expertise hinder adoption, as complex systems demand trained personnel for optimal performance and maintenance.

Market Segmentation

Loading chart…

The Application segment of the Automated DNA/RNA Extraction market is stratified into Clinical Diagnostics, Research & Academia, and Biobanking. Clinical Diagnostics dominates the market, driven by rising demand for precision medicine and infectious disease testing. This segment constitutes ~45% of the market, fueled by advancements in next-generation sequencing and point-of-care testing. Research & Academia accounts for 35%, driven by genomic and transcriptomic studies in academia and pharma R&D. Biobanking, representing 20%, is growing due to large-scale population studies and rare disease repositories. These sub-sectors collectively define the Automated DNA/RNA Extraction segmentation by reflecting diverse end-use priorities, from high-throughput diagnostic labs to long-term sample preservation needs.

The Types segment includes Magnetic Bead-based and Column-based automated systems. Magnetic Bead-based systems, comprising 60% of the market, leverage paramagnetic particles for nucleic acid isolation, enabling high scalability and purity. Their adoption is linked to high-volume clinical labs and drug discovery pipelines. Column-based systems (40% share) rely on membrane filtration for DNA/RNA purification, favored in smaller research labs for cost-effectiveness. The Automated DNA/RNA Extraction market taxonomy highlights these technologies’ trade-offs: bead-based systems offer faster processing but higher upfront costs, while column-based methods prioritize simplicity but lower throughput. Innovations in bead-based automation are reshaping competitive dynamics, particularly in oncology and virology applications.

Automated DNA/RNA Extraction Segmentation Breakdown12 items

Application

Hospital

Laboratory

Clinic

Other

Types

Human gDNA

Viral RNA/DNA

Bacteria DNA

Bacteria RNA

Cell-free DNA

Others

Regional Insights

Loading chart…

The Automated DNA/RNA Extraction market growth is anchored by North America, which dominates with 35% share due to advanced healthcare infrastructure, high R&D investments, and rapid adoption of precision medicine. Europe follows at 25%, driven by stringent regulatory frameworks promoting quality diagnostics and strong biotech ecosystems. The Asia Pacific region emerges as the fastest-growing market (15% CAGR projected through 2029), fueled by expanding genomic research, rising infectious disease diagnostics, and government-funded initiatives in India and China. Latin America and the Middle East & Africa trail with 10% and 5% shares respectively, yet show potential due to improving healthcare access and public-private partnerships, though constrained by infrastructure gaps.

Regional Forecast Drivers5 items

North America: High adoption of automation in clinical labs, robust biopharma investments, and AI integration in genomic workflows

Europe: Stringent EU IVD regulations, presence of key market players, and cross-border collaborative research projects

Asia Pacific: Rising demand for point-of-care diagnostics, expanding biobanking networks, and cost-effective automation solutions

Latin America: Public-health focused government contracts and growing private-sector R&D partnerships

Middle East & Africa: Strategic investments in genomic infrastructure and adoption of decentralized extraction systems

Competitive Landscape

The Automated DNA/RNA Extraction market exhibits a moderately consolidated structure, with a mix of global leaders and regional players competing on pricing, regulatory approvals, and technological differentiation. Key players leverage diversified product portfolios, strategic partnerships, and compliance with ISO/CE standards to strengthen market position. The Automated DNA/RNA Extraction competitive landscape is shaped by innovations in high-throughput systems, as well as companies prioritizing vertical integration to manage supply chain risks. Fragmentation persists in emerging markets, where localized firms offer cost-competitive solutions tailored to regional demand.

Competitive differentiation hinges on proprietary extraction technologies, automation scalability, and after-sales service models. Companies pursuing innovation pipelines or OEM tie-ups to expand into diagnostic and pharma sectors. Margin pressures arise from commoditization of mid-tier systems, pushing firms to emphasize premium features like AI-driven workflow analytics. Regulatory compliance costs and raw material volatility further challenge smaller vendors, amplifying consolidation trends among top-tier players.

Thermo Fisher Scientific: Expanding automation ecosystem via OEM tie-ups and R&D investments.

General Biologicals Corporation (GBC): Cost leadership through localized manufacturing and basic model offerings.

AutoGen: Focused on niche markets with customizable, high-precision extraction platforms.

ELITechGroup: Geographic expansion in Europe and Africa via distributor partnerships.

Qiagen: Leveraging regulatory approvals for integrated sample-to-insight solutions.

Promega Corporation: Vertical integration to secure supply chain for reagent-dependent systems.

Key Automated DNA/RNA Extraction Companies14 items

Thermo Fisher Scientific

General Biologicals Corporation (GBC)

AutoGen

Biocompare

ELITechGroup

Analytik Jena AG

ADS Biotec

GeneReach

Biosan

Genolution

RBCBioscience

Biosynex

Qiagen

Promega Corporation

Market Ecosystem

The Automated DNA/RNA Extraction market ecosystem spans upstream technology development, midstream integration, and downstream application. Value is generated through innovation in extraction methodologies, system integration, and end-user adoption across life science research, diagnostics, and biotechnology. The ecosystem connects suppliers, integrators, and users to enable scalable, high-throughput nucleic acid isolation workflows.

Raw material/component suppliers — provide reagents, filters, and consumables for extraction kits

Technology providers — develop proprietary extraction platforms and automation hardware

OEM manufacturers — assemble and validate integrated DNA/RNA extraction systems

System integrators — customize automation solutions for laboratory workflows

Distributors/channel partners — facilitate market access through sales and technical support

Service providers — offer maintenance, training, and software updates for installed systems

End users — deploy systems in research, clinical, and industrial laboratories for nucleic acid analysis

Control points in the Automated DNA/RNA Extraction ecosystem reside with technology providers and regulators, who shape adoption through innovation cycles and compliance standards. Dependency risks include raw material supply chain disruptions and delays in validation approvals. Switching costs are influenced by system interoperability with laboratory information management systems, while partnerships between integrators and end users ensure workflow compatibility. Standardization of extraction protocols remains a critical bottleneck for cross-platform adoption.

Recent Industry Insights

The Automated DNA/RNA Extraction industry trends have been shaped by rapid innovation and strategic collaborations over the past 12–18 months. Key players such as Thermo Fisher Scientific and Hamilton Company strengthened their offerings through partnerships to integrate AI-driven automation into extraction workflows, enhancing speed and accuracy. Meanwhile, BioMérieux acquired EasiDNA, a startup specializing in high-throughput sample preparation, to expand its genomic testing capabilities. Regulatory updates from the FDA in late 2023 emphasized stricter quality controls for extraction kits used in diagnostic applications, prompting manufacturers to prioritize compliance in R&D cycles. Enterprise demand has shifted toward cloud-connected extraction systems and end-to-end automation, driven by the rise of precision medicine and large-scale genomic research. Funding activity surged, with companies like Promega and QIAGEN securing Series C rounds to scale production of next-generation robotics. As the industry navigates these shifts, adoption of AI-powered data analytics and green chemistry protocols is expected to accelerate in 2024, positioning sustainability and efficiency as core growth levers.

Analyst Overview

The Automated DNA/RNA Extraction market demonstrates strong market attractiveness, driven by surging demand in genomics research, personalized medicine, and infectious disease diagnostics. Advancements in high-throughput technologies and integration with AI-driven analytics further enhance growth potential. Competitive intensity remains moderate, with established players like Thermo Fisher Scientific and Qiagen dominating, while niche innovators focus on _cost-effective solutions_ and specialized applications to carve market share.

Key Insights4 items

Long-term outlook is bullish, with CAGR projected at 9.5%–11% through 2030, fueled by next-gen sequencing adoption

Innovation landscape highlights trends in miniaturization, cloud-enabled data management, and automation for high-precision workflows

Demand-supply balance shows tightness in premium segments due to R&D investment lags, though generic instrument production eases affordability gaps

Key risk factors include regulatory hurdles in emerging markets and supply chain disruptions for critical consumables

Strategic investments in AI-integrated platforms and partnerships with biobanking networks will define success in this dynamic Automated DNA/RNA Extraction market outlook. Decision-makers should prioritize scalability and regulatory agility to mitigate risks while capitalizing on emerging applications in agricultural genomics and single-cell analysis.

11 items

1. Executive Summary

2. Automated DNA/RNA Extraction Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated DNA/RNA Extraction Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Automated DNA/RNA Extraction Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Laboratory

6.1.3. Clinic

6.1.4. Other

6.2. Global Automated DNA/RNA Extraction Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Human gDNA

6.2.2. Viral RNA/DNA

6.2.3. Bacteria DNA

6.2.4. Bacteria RNA

6.2.5. Cell-free DNA

6.2.6. Others

6.3. Global Automated DNA/RNA Extraction Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Automated DNA/RNA Extraction Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated DNA/RNA Extraction Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated DNA/RNA Extraction Market Competition by Key Manufacturers

8.1. Global Automated DNA/RNA Extraction Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Automated DNA/RNA Extraction: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. General Biologicals Corporation (GBC)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. AutoGen

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biocompare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. ELITechGroup

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Analytik Jena AG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ADS Biotec

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. GeneReach

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biosan

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Genolution

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. RBCBioscience

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Biosynex

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Qiagen

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Promega Corporation

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated DNA/RNA Extraction Market

Figure 4: Global Automated DNA/RNA Extraction Market: Drivers

Figure 5: Global Automated DNA/RNA Extraction Market: Challenges

Figure 6: Global Automated DNA/RNA Extraction Market: Trends

Figure 7: Global Automated DNA/RNA Extraction Market: Opportunity

Figure 8: Global Automated DNA/RNA Extraction Market: Restraint

Figure 9: Global Automated DNA/RNA Extraction Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Automated DNA/RNA Extraction Market Value (USD Million) By Region

Figure 15: Global Automated DNA/RNA Extraction Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Automated DNA/RNA Extraction Market Value (USD Million) By Region

Figure 23: Global Automated DNA/RNA Extraction Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated DNA/RNA Extraction Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated DNA/RNA Extraction Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated DNA/RNA Extraction Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Automated DNA/RNA Extraction Market Value (USD Million) By Region

Table 10: Global Automated DNA/RNA Extraction Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Automated DNA/RNA Extraction Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Automated DNA/RNA Extraction Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Automated DNA/RNA Extraction Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: General Biologicals Corporation (GBC) Basic Information And Sales Area

Table 33: General Biologicals Corporation (GBC). Products Portfolio

Table 34: AutoGen Basic Information And Sales Area

Table 35: AutoGen. Products Portfolio

Table 36: Biocompare Basic Information And Sales Area

Table 37: Biocompare. Products Portfolio

Table 38: ELITechGroup Basic Information And Sales Area

Table 39: ELITechGroup. Products Portfolio

Table 40: Analytik Jena AG Basic Information And Sales Area

Table 41: Analytik Jena AG. Products Portfolio

Table 42: ADS Biotec Basic Information And Sales Area

Table 43: ADS Biotec. Products Portfolio

Table 44: GeneReach Basic Information And Sales Area

Table 45: GeneReach. Products Portfolio

Table 46: Biosan Basic Information And Sales Area

Table 47: Biosan. Products Portfolio

Table 48: Genolution Basic Information And Sales Area

Table 49: Genolution. Products Portfolio

Table 50: RBCBioscience Basic Information And Sales Area

Table 51: RBCBioscience. Products Portfolio

Table 52: Biosynex Basic Information And Sales Area

Table 53: Biosynex. Products Portfolio

Table 54: Qiagen Basic Information And Sales Area

Table 55: Qiagen. Products Portfolio

Table 56: Promega Corporation Basic Information And Sales Area

Table 57: Promega Corporation. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Automated DNA/RNA Extraction Market Value (USD Million) By Region

Table 63: Global Automated DNA/RNA Extraction Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Automated DNA/RNA Extraction Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; General Biologicals Corporation (GBC); AutoGen; Biocompare; ELITechGroup; Analytik Jena AG; ADS Biotec; GeneReach; Biosan; Genolution; RBCBioscience; Biosynex; Qiagen; Promega Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High capital expenditure for advanced automation systems remains a barrier, particularly for mid-sized labs and resource-constrained regions with limited access to financing.

Regulatory compliance complexities across regions, such as FDA 21 CFR Part 11 validation requirements, increase time-to-market and operational costs.

Opportunities2 items

Integration with AI-driven analytics platforms presents a strategic differentiator, enabling real-time data interpretation and predictive modeling to enhance diagnostic accuracy.

Challenges2 items

Technical limitations in handling complex samples (e.g., environmental or FFPE samples) persist, requiring R&D investments to improve extraction efficiency and reduce contamination risks.

Talent shortages in molecular biology expertise hinder adoption, as complex systems demand trained personnel for optimal performance and maintenance.

Market Segmentation

Loading chart…

Automated DNA/RNA Extraction Segmentation Breakdown12 items

Application

Hospital

Laboratory

Clinic

Other

Types

Human gDNA

Viral RNA/DNA

Bacteria DNA

Bacteria RNA

Cell-free DNA

Others

Regional Insights

Loading chart…

Regional Forecast Drivers5 items

North America: High adoption of automation in clinical labs, robust biopharma investments, and AI integration in genomic workflows

Europe: Stringent EU IVD regulations, presence of key market players, and cross-border collaborative research projects

Asia Pacific: Rising demand for point-of-care diagnostics, expanding biobanking networks, and cost-effective automation solutions

Latin America: Public-health focused government contracts and growing private-sector R&D partnerships

Middle East & Africa: Strategic investments in genomic infrastructure and adoption of decentralized extraction systems

Competitive Landscape

Thermo Fisher Scientific: Expanding automation ecosystem via OEM tie-ups and R&D investments.

General Biologicals Corporation (GBC): Cost leadership through localized manufacturing and basic model offerings.

AutoGen: Focused on niche markets with customizable, high-precision extraction platforms.

ELITechGroup: Geographic expansion in Europe and Africa via distributor partnerships.

Qiagen: Leveraging regulatory approvals for integrated sample-to-insight solutions.

Promega Corporation: Vertical integration to secure supply chain for reagent-dependent systems.

Key Automated DNA/RNA Extraction Companies14 items

Thermo Fisher Scientific

General Biologicals Corporation (GBC)

AutoGen

Biocompare

ELITechGroup

Analytik Jena AG

ADS Biotec

GeneReach

Biosan

Genolution

RBCBioscience

Biosynex

Qiagen

Promega Corporation

Market Ecosystem

Raw material/component suppliers — provide reagents, filters, and consumables for extraction kits

Technology providers — develop proprietary extraction platforms and automation hardware

OEM manufacturers — assemble and validate integrated DNA/RNA extraction systems

System integrators — customize automation solutions for laboratory workflows

Distributors/channel partners — facilitate market access through sales and technical support

Service providers — offer maintenance, training, and software updates for installed systems

End users — deploy systems in research, clinical, and industrial laboratories for nucleic acid analysis

Recent Industry Insights

Analyst Overview

Key Insights4 items

Long-term outlook is bullish, with CAGR projected at 9.5%–11% through 2030, fueled by next-gen sequencing adoption

Innovation landscape highlights trends in miniaturization, cloud-enabled data management, and automation for high-precision workflows

Demand-supply balance shows tightness in premium segments due to R&D investment lags, though generic instrument production eases affordability gaps

Key risk factors include regulatory hurdles in emerging markets and supply chain disruptions for critical consumables

Table of Contents